POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No114/2012
Date of issue:2012-11-15
Short name of the issuer
SOPHARMA AD
Subject
Current report 114 buy back 15112012
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from 8 November 2012 up to and including 14 November 2012 the Company bought 56111 own shares representing 0.043% of the share capital of the Company, to the total value of BGN 127209.75 on the Bulgarian Stock Exchange. The average price per share was BGN 2.27. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers. The total number of own shares after these transactions is 3427889, representing 2.60% of the share capital of the Company.
Annexes
FileDescription
Current report 114 buy back 15112012.docCurrent report 114 buy back 15112012
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2012-11-15Ognian DonevExecutive Director